<DOC>
	<DOCNO>NCT02875080</DOCNO>
	<brief_summary>The ratio geometric mean ODT formulation reference formulation ( conventional tablet ) bioavailability variable ( Cmax , AUCt , AUCâˆž brexpiprazole ( OPC-34712 ) ) .</brief_summary>
	<brief_title>Evaluation Study Bioavailability Brexpiprazole Orally Disintegrating Tablets Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Capable provide write informed consent prior initiation trialrelated procedure , able , opinion investigator , comply requirement trial Clinically significant abnormality time screen ( eg , significant deviation reference range ) medical history , opinion investigator sponsor may place subject risk interfere outcome variable , include drug absorption , distribution , metabolism , excretion History serious mental disorder History drug alcohol abuse within 2 year prior screen History significant drug allergy Use investigational drug within 120 day prior first dose trial drug Use tobacco product daily exposure secondhand smoke within 2 month prior screen Consumption grapefruit , grapefruit product , Seville oranges , Seville orange product , starfruit , starfruit product within 72 hour prior dose Use prescription , overthecounter , herbal medication , vitamin supplement , St. John 's Wort within 14 day prior first dose trial drug , antibiotic within 30 day prior first dose trial drug History major surgery digestive tract ( exclude appendectomy ) Any subject , opinion investigator , participate trial</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>